» Articles » PMID: 15323430

[Effect of Genistein on Expression of Angiogenesis Related Factors in HER-2/neu-overexpressing Breast Cancer Cells]

Overview
Specialty Biology
Date 2004 Aug 25
PMID 15323430
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

To study the molecular mechanism of inhibition of angiogenesis in HER-2/neu-overexpressing breast cancer by genistein, HER-2/neu negative expression breast cancer MCF-7 cells were transfected with HER-2/neu to establish HER-2/neu-overexpressing MCF-7 cells (named MCF-7/HER-2). Expression of vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), matrix metalloproteinase-2,9 (MMP-2,9) in MCF-7, MCF-7/HER-2 as well as genistein-treated MCF-7/HER-2 were measured by immunocytochemistry and Western blot. We found that the expression of VEGF, MMP-2,9 and uPA in MCF-7/HER-2 cells were highter than that in MCF-7 cells, those angiogenesis related factors expression in MCF-7/HER-2 cells significantly decreased after treatment with genistein. Genistein could inhibit expression of angiogenesis-related factors VEGF, MMP-2,9 and uPA in HER-2/neu-overexpressing breast cancer cells, and this may be part of molecular mechanism of its anti-angiogenesis in HER-2/neu-overexpressing breast cancer.

Citing Articles

Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation.

Yu X, Zhu J, Mi M, Chen W, Pan Q, Wei M Med Oncol. 2010; 29(1):349-57.

PMID: 21132400 DOI: 10.1007/s12032-010-9770-2.